The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II trial of y-90 radioembolization in patients with progressive hepatic metastases from neuroendocrine carcinoma at an NCI-designated comprehensive cancer center.
Vaibhav Sahai
No relevant relationships to disclose
Halla Sayed Nimeiri
No relevant relationships to disclose
Mary Frances Mulcahy
No relevant relationships to disclose
Riad Salem
No relevant relationships to disclose
Al Bowen Benson
No relevant relationships to disclose